NeuroCytonix Bahamas Ltd.
About NeuroCytonix Bahamas Ltd.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Capital Raise via Active Managed Certificate (AMC) T: - FT: Capital Raise via Active Managed Certificate (AMC) |
A: 12000000 MR: - FA: 12 million FAN: 12000000 |
D: 2023-03-02 FD: 2023-03-02 |
2 investors |
| 2 |
RT: AMC Capital Raise T: - FT: AMC Capital Raise |
A: 12000000 MR: - FA: $12 million FAN: 12000000 |
D: 2023-03-02 FD: 2023-03-02 |
2 investors |
Growth Metrics
Team & Leadership
J. Roberto Trujillo
Chairman and CEO
Laurent Lavigne du Cadet
Chief Financial Officer and Chief Operating Officer
Robert C. Gallo
American biomedical researcher
Vanderlei S. Bagnato
Brazilian physicist, researcher, and university professor
Rajah V. Kumar
Senior Scientific Co-Chair
Jeff Balagna
Vice Chairman of the Board
Recent News
NeuroCytonix Bahamas Ltd. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- neurocytonix.com
- Industries
- Biomedical Technology
- Company Size
- ~240 employees (est.)
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro